Recro Pharma logo
Recro Pharma REPH
$ 1.4 -4.76%

Annual report 2023
added 03-22-2024

report update icon

Recro Pharma Balance Sheet 2011-2024 | REPH

Annual Balance Sheet Recro Pharma

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-6.65 M 17.1 M 71.3 M 85.8 M 91.7 M 25.7 M -3.89 M -40.1 M 9.98 M -19.7 M -188 K 10.1 M 8.14 M

Long Term Debt

339 K 31 M 95.5 M 108 M 110 M 64.2 M 53.6 M 22.2 M 25.2 M - - - -

Long Term Debt Current

1.1 M 1.08 M 1.06 M 1.47 M 148 K - - 2.24 M 4.52 M - - - -

Total Non Current Liabilities

- - - - 111 M 146 M 107 M 95.1 M 88.9 M - - 5.44 M 5.03 M

Total Current Liabilities

50 M 22.8 M 17.7 M 7.8 M 6.48 M 29 M 49.9 M 16.3 M 9.49 M 1.45 M - - -

Total Liabilities

94.8 M 97.6 M 118 M 118 M 117 M 175 M 157 M 111 M 98.3 M 1.45 M 1.02 M 15.7 M 13.6 M

Deferred Revenue

543 K 2.21 M 2.31 M 1.45 M 337 K 66 K 546 K 418 K - - - - -

Retained Earnings

-279 M -266 M -246 M -234 M -207 M -188 M -111 M -61.3 M -31.1 M -34.1 M -18 M -15.6 M -13.6 M

Total Assets

153 M 157 M 160 M 103 M 110 M 155 M 186 M 183 M 139 M 20.4 M 1.03 M 154 K 25.7 K

Cash and Cash Equivalents

8.1 M 15 M 25.2 M 23.8 M 19.1 M 38.5 M 61 M 64.5 M 19.8 M 19.7 M 12.8 K - -

Book Value

58.7 M 59.9 M 42.1 M -14.1 M -6.71 M -19.5 M 28.8 M 71.6 M 40.4 M 18.9 M 2.34 K -15.6 M -13.6 M

Total Shareholders Equity

58.7 M 59.9 M 42.1 M -14.1 M -6.71 M -19.5 M 28.8 M 71.6 M 40.4 M 18.9 M -18 M - -

All numbers in USD currency

Quarterly Balance Sheet Recro Pharma

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

27.4 M 31 M 30.5 M 31 M 95.5 M 94.4 M 93.2 M 92.1 M 91 M 89.8 M 88.9 M 108 M 108 M 108 M 108 M 110 M 110 M 110 M 110 M 64.2 M 64.2 M 64.2 M 64.2 M 53.6 M 53.6 M 53.6 M 53.6 M 22.2 M 22.2 M 22.2 M 22.2 M 25.2 M 25.2 M 25.2 M 25.2 M - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

93.3 M 94.4 M 94 M 97.6 M 116 M 116 M 113 M 118 M 113 M 96 M 98.3 M 118 M 118 M 118 M 118 M 117 M 117 M 117 M 117 M 175 M 175 M 175 M 175 M 157 M 157 M 157 M 157 M 111 M 111 M 111 M 111 M 98.3 M 98.3 M 98.3 M 98.3 M 1.45 M 1.45 M 1.45 M 1.45 M 12.9 M 12.9 M 12.9 M 12.9 M - - - - - - - -

Deferred Revenue

1.31 M 1.28 M 1.76 M 2.21 M 2.37 M 2.22 M 1.84 M 2.31 M 2.32 M 1.07 M 1.4 M 1.45 M 1.45 M 1.45 M 786 K 337 K 775 K 637 K 548 K 66 K 66 K 66 K 66 K 546 K 546 K 546 K 546 K 418 K 418 K 418 K 418 K - - - - - - - - - - - - - - - - - - - -

Retained Earnings

-278 M -274 M -270 M -266 M -256 M -253 M -250 M -246 M -243 M -240 M -241 M -234 M -234 M -234 M -234 M -207 M -207 M -207 M -207 M -188 M -188 M -188 M -188 M -111 M -111 M -111 M -111 M -61.3 M -61.3 M -61.3 M -61.3 M -31.1 M -31.1 M -31.1 M -31.1 M -34.1 M -34.1 M -34.1 M -34.1 M -18 M - - - - - - - - - - -

Total Assets

152 M 149 M 150 M 157 M 151 M 153 M 152 M 160 M 158 M 122 M 89.6 M 103 M 103 M 103 M 103 M 110 M 110 M 110 M 110 M 155 M 155 M 155 M 155 M 186 M 186 M 186 M 186 M 183 M 183 M 183 M 183 M 139 M 139 M 139 M 139 M 20.4 M 20.4 M 20.4 M 20.4 M 851 K 851 K 851 K 851 K - - - - - - - -

Cash and Cash Equivalents

8.16 M 4.7 M 6.29 M 15 M 11.6 M 15.5 M 15.3 M 25.2 M 23.5 M 45.7 M 11.6 M 23.8 M 23.8 M 23.8 M 23.8 M 19.1 M 19.1 M 19.1 M 19.1 M 38.5 M 38.5 M 38.5 M 38.5 M 61 M 61 M 61 M 61 M 64.5 M 64.5 M 64.5 M 64.5 M 19.8 M 19.8 M 19.8 M 19.8 M 19.7 M 19.7 M 19.7 M 19.7 M 13 K 12.8 K 12.8 K 12.8 K 53.3 K - - - - - - -

Book Value

58.3 M 54.3 M 56 M 59.9 M 35.2 M 37.3 M 39.2 M 42.1 M 44.5 M 26.4 M -8.72 M -14.1 M -14.1 M -14.1 M -14.1 M -6.71 M -6.71 M -6.71 M -6.71 M -19.5 M -19.5 M -19.5 M -19.5 M 28.8 M 28.8 M 28.8 M 28.8 M 71.6 M 71.6 M 71.6 M 71.6 M 40.4 M 40.4 M 40.4 M 40.4 M 18.9 M 18.9 M 18.9 M 18.9 M -12.1 M -12.1 M -12.1 M -12.1 M - - - - - - - -

Total Shareholders Equity

58.3 M 54.3 M 56 M 59.9 M 35.2 M 37.3 M 39.2 M 42.1 M 44.5 M 26.4 M -8.72 M -14.1 M -14.1 M -14.1 M -14.1 M -6.71 M -6.71 M -6.71 M -6.71 M -19.5 M -19.5 M -19.5 M -19.5 M 28.8 M 28.8 M 28.8 M 28.8 M 71.6 M 71.6 M 71.6 M 71.6 M 40.4 M 40.4 M 40.4 M 40.4 M 18.9 M 18.9 M 18.9 M 18.9 M -18 M -18 M -18 M -18 M -15.6 M - - - - - - -

All numbers in USD currency